Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma
Clinical trial NCT07209163 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07209163
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2026-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.